Management of humoral secondary immunodeficiency in hematol… — KazNU

91ý

Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives

2023 · Review

Publication year

2023

CiteScore

4,0

SJR

0,694

SNIP

0,62

Source: Leukemia Research

DOI:

Scopus:

Sustainable Development Goals (2025)

SDG 3

Fields of knowledge

Cancer Research Hematology Oncology